Towards Better Sinomenine-Type Drugs to Treat Rheumatoid Arthritis: Molecular Mechanisms and Structural Modification
Sinomenine is the main component of the vine <i>Sinomenium acutum</i>. It was first isolated in the early 1920s and has since attracted special interest as a potential anti-rheumatoid arthritis (RA) agent, owing to its successful application in traditional Chinese medicine for the treatm...
Main Authors: | Cuili Zhang, Shujie Zhang, Jingjing Liao, Zipeng Gong, Xin Chai, Haining Lyu |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-12-01
|
Series: | Molecules |
Subjects: | |
Online Access: | https://www.mdpi.com/1420-3049/27/24/8645 |
Similar Items
-
Benefit-risk assessment of traditional Chinese medicine preparations of sinomenine using multicriteria decision analysis (MCDA) for patients with rheumatoid arthritis
by: Gao Xiang, et al.
Published: (2023-02-01) -
Efficacy and safety of TCMs with anti-inflammatory effect in patients with rheumatoid arthritis: A network meta-analysis
by: Jinying Fang, et al.
Published: (2023-03-01) -
Recent Advancements in Drug Delivery of Sinomenine, A Disease-Modifying Anti-Rheumatic Drug
by: Xin Chen, et al.
Published: (2022-12-01) -
Effects of Metabolic Disorders in Immune Cells and Synoviocytes on the Development of Rheumatoid Arthritis
by: Alexander V. Blagov, et al.
Published: (2022-07-01) -
Decoding the Microbiome’s Influence on Rheumatoid Arthritis
by: Donatella Coradduzza, et al.
Published: (2023-08-01)